SpiderRock Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.95M | Buy |
3,758
+251
| +7% | +$264K | 0.06% | 152 |
|
|
2024
Q2 | $3.69M | Sell |
3,507
-297
| -8% | -$312K | 0.07% | 144 |
|
|
2024
Q1 | $3.65M | Buy |
+3,804
| New | +$3.65M | 0.09% | 133 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 135 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 123 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 119 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 111 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 108 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 111 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 112 |
|
|
2017
Q4 | – | Hold |
0
| – | -$280K | – | 232 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 49 |
|
|
2017
Q2 | – | Hold |
0
| – | -$563K | – | 549 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 25 |
|